169 related articles for article (PubMed ID: 13185412)
21. MYASTHENIA gravis.
Br Med J; 1956 Jun; 1(4978):1283-4. PubMed ID: 13316135
[No Abstract] [Full Text] [Related]
22. WIN 8077 in the treatment of sixty myasthenia gravis patients; a twelve-month report.
SCHWAB RS
Am J Med; 1955 Nov; 19(5):734-6. PubMed ID: 13268473
[No Abstract] [Full Text] [Related]
23. [Mysuran, a new preparation for myasthenia gravis].
OFTEDAL SI
Nord Med; 1957 May; 57(21):748-9. PubMed ID: 13457385
[No Abstract] [Full Text] [Related]
24. [Case of myasthenia gravis].
KATILA O; KIVALO E
Duodecim; 1955; 71(4):605-10. PubMed ID: 14391241
[No Abstract] [Full Text] [Related]
25. [First therapeutic results with mytelase (mysuran, win 8077) in myasthenia].
DESMEDT JE
Acta Neurol Psychiatr Belg; 1957 Feb; 57(2):94-103. PubMed ID: 13424193
[No Abstract] [Full Text] [Related]
26. Advantages of pyridostigmine bromide (mestinon) and edrophonium chloride (tensilon) in the treatment of transitory myasthenia gravis in the neonatal period.
MOORE H
N Engl J Med; 1955 Dec; 253(24):1075-6. PubMed ID: 13272842
[No Abstract] [Full Text] [Related]
27. Urecholine in myasthenia gravis.
SCHWARZ H
Can Med Assoc J; 1955 Mar; 72(5):346-51. PubMed ID: 14352096
[No Abstract] [Full Text] [Related]
28. [A new drug, pyridostigmine, in therapy of myasthenia].
FURTADO D
J Med (Oporto); 1954 Apr; 23(586):953-9. PubMed ID: 13162673
[No Abstract] [Full Text] [Related]
29. WIN 8077 in treatment of myasthenia gravis; use of N,N'-bis (2-diethylaminoethyl) oxamide bis-2-chlorobenzyl chloride in fifty patients.
SCHWAB RS; MARSHALL CK; TIMBERLAKE W
J Am Med Assoc; 1955 Jun; 158(8):625-8. PubMed ID: 14381226
[No Abstract] [Full Text] [Related]
30. [Transient neonatal myasthenia gravis].
Váradi V; Nagy A; György I; Machay T; Papp Z
Orv Hetil; 1995 Feb; 136(8):401-5. PubMed ID: 7885685
[TBL] [Abstract][Full Text] [Related]
31. [Further progress in therapy of myasthenic syndrome].
STRUPPLER A
Med Monatsschr; 1953 Jul; 7(7):428-32. PubMed ID: 13098853
[No Abstract] [Full Text] [Related]
32. [Myasthenia and mediastinal tumor; favorable effect of a new anti-myasthenic preparation].
SUTTER JM; LARMANDE AM
Rev Otoneuroophtalmol; 1953; 25(4):231-4. PubMed ID: 13112901
[No Abstract] [Full Text] [Related]
33. Clinical evaluation of ambenonium (mysuran) chloride.
WESTERBERG MR
AMA Arch Neurol Psychiatry; 1956 Jan; 75(1):91-4. PubMed ID: 13275166
[No Abstract] [Full Text] [Related]
34. [Myasthenia gravis].
Stackhouse J
Infirm Can; 1974 Mar; 16(3):28-33. PubMed ID: 4493945
[No Abstract] [Full Text] [Related]
35. [Clinical trials with a new anti-myasthenic drug: N, N'-bis (2-diethylaminoethyl)-oxamide bis-2-chlorobenzyl chloride (Win 8077)].
ALAJOUANINE T; CASTAIGNE P; BOURGUIGNON A; CAMBIER J
Therapie; 1958; 13(5):799-804. PubMed ID: 13625192
[No Abstract] [Full Text] [Related]
36. Effect of 3-hydroxy phenyl-dimethylethylammonium chloride (tensilon) in myasthenia gravis.
WESTERBERG MR; MAGEE KR; SHIDEMAN FE
Med Bull (Ann Arbor); 1951 Sep; 17(9):311-6. PubMed ID: 14893613
[No Abstract] [Full Text] [Related]
37. Myasthenia gravis. Diagnostic methods and control measures for a chronic disease.
Juhn MS
Postgrad Med; 1993 Oct; 94(5):161-4, 167-71, 174. PubMed ID: 8415329
[TBL] [Abstract][Full Text] [Related]
38. [Results of x-ray irradiation of the thymus gland in myasthenia gravis].
Raczkiewicz J
Neurol Neurochir Pol; 1970; 4(3):357-9. PubMed ID: 5455386
[No Abstract] [Full Text] [Related]
39. [Preliminary results with armin (ethyl-ethoxy phosphoryl p-nitrophenolate) in myasthenia gravis].
VOJVODIC V; GRBESA B; STEVANOVIC M; BINENFELD Z; GAZIVODA N; BARYLA K; BOZIC V
Vojnosanit Pregl; 1960 Nov; 17():1167-70. PubMed ID: 13781940
[No Abstract] [Full Text] [Related]
40. Symposium on therapeutic controversies. Myasthenia gravis. Plasmapheresis in the treatment of myasthenia gravis.
Lisak RP; Schotland DL
Trans Am Neurol Assoc; 1978; 103():292-302. PubMed ID: 757080
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
